Skip to main content
. 2026 Jul 27;21(3):136–151. doi: 10.26599/JOTO.2026.9540064

Table B. Clinical characteristics of patients (neurological symptoms).

Pt* Age Side Pretreatement/
Posttreatement
CN VII function
(HB score) **
Pretreatement/
Posttreatement other
CN function
Pretreatement/
Posttreatement
cephalgia (NRS)***
*Pt (patient).
** House Brackmann score, upwards (superior)/outwards (lateral) facial movement (I-VI) [30].
*** NRS-numerical pain rating scale (0-10) [30].
****After the 13th month of treatment.
1. 73 right HB V/VI HB V/V normal normal moderate (NRS 5- 6) no pain
(NRS 0)
2. 78 left HB II/II HB I/I CN X: paresis CN X: paresis severe
(NRS 7)
severe
(NRS 7)
3. 84 right HB VI/VI HB VI/VI**** normal normal extreme
(NRS 8)
severe
(NRS 7)
4. 51 left HB I/III HB I/I CN VI: ipsilateral paresis
CN IX: contralateral paresis
CN XII: bilateral paresis
CN VI: normal
CN IX: normal CN XII: normal
moderate (NRS 4) very severe (NRS 8)
5. 50 right HB III/VI

HB IV/V (during the recurrence)
HB I/I

HB V/V
(after the recurrence)
normal

CN IX: ipsilateral paresis CN X: ipsilateral paresis
CN XII: ipsilateral paresis (during the recurrence)
normal

CN IX: normal
CN X: normal
CN XII: normal
mild
(NRS 2-3)
no pain
(NRS 0)